Siemens Demonstrates Groundbreaking, New Innovations in Imaging, Diagnostics and Therapy at AACC 2020 Virtual Event
By LabMedica International staff writers
Posted on 14 Dec 2020
Siemens Healthineers (Erlangen, Germany) provided live demonstrations of the company’s groundbreaking, new innovations in imaging, diagnostics and therapy at the all virtual 2020 AACC Annual Scientific Meeting held on December 13-17.Posted on 14 Dec 2020
Attendees of the 2020 AACC Virtual Meeting Platform discovered the power of comprehensive multidisciplinary workflow solution by viewing how Siemens’ intelligent analyzers, Atellica Diagnostics IT, Aptio Automation, and the company’s Healthcare Consulting Solutions team combined can take workflow optimization to the next level. Atellica Diagnostics IT provides scalable, easy-to-use solutions to simplify tasks and maximize the effectiveness of the laboratory and its staff. Siemens demonstrated how Atellica Diagnostics IT can enhance visibility, automate processes, and centralize management across instruments, automation, sites, and networks. The company showcased its broad range of hemostasis testing solutions that offer the scalability needed for accurate testing in both low and high-volume testing environments.
Siemens also offered expert-led virtual demonstrations of its broad portfolio of trusted assays for nearly every type of disease that deliver accurate, clinically relevant results, at all access points for patient testing. Attendees were also able to engage in one-on-one conversations, have exclusive access to Siemens’ experts, and participate in live demonstrations of the company’s critical care testing products and chronic disease management at the point of care. The company also demonstrated its full range of antibody, antigen and molecular SARS-CoV-2 tests at the all virtual 2020 AACC.